Attached files

file filename
EX-10.1 - EXHIBIT 10.1 AMENDMENT NO. 2, DATED FEBRUARY 21, 2018, TO EMPLOYMENT OFFER LETTE - SIGMA LABS, INC.f8k022118_ex10z1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): February 21, 2018

 

SIGMA LABS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Nevada

 

001-38015

 

27-1865814

(State or Other

Jurisdiction of

Incorporation

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

 

 

 

 

3900 Paseo del Sol, Santa Fe, New Mexico 87507

(Address of Principal Executive Offices) (Zip Code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Registrant’s telephone number, including area code: (505) 438-2576

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [   ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

 

 


1


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As previously disclosed, on September 18, 2017, Sigma Labs, Inc. (“we,” “our,” “us” or the “Company”) and Ronald Fisher, the Company’s Vice President of Business Development, entered into Amendment No. 1 to Mr. Fisher’s Employment Offer Letter Agreement, effective August 10, 2015, pursuant to which, effective as of February 11, 2017, item 2, entitled “Performance Bonuses,” of Exhibit A of Mr. Fisher’s Employment Offer Letter Agreement was deleted in its entirety and replaced with the new item 2 that was set forth in the amendment to Employment Offer Letter Agreement. Such amendment provided that Mr. Fisher would become entitled to receive performance-based stock and cash bonuses if certain milestones were satisfied by February 11, 2018, so long as Mr. Fisher remained an employee of the Company as of the date the applicable milestone was satisfied. On February 21, 2018, the Company and Mr. Fisher entered into Amendment No. 2 to Mr. Fisher’s Employment Offer Letter Agreement, pursuant to which the February 11, 2018 date referred to in the immediately preceding sentence was extended to December 31, 2018. No other changes to Mr. Fisher’s Employment Offer Letter Agreement were made pursuant to this amendment.

 

Amendment No. 2 to Employment Offer Letter Agreement is filed hereto as Exhibit 10.1 and is incorporated into this Item 5.02 by reference. The foregoing description of Amendment No. 2 to Employment Offer Letter Agreement is qualified in its entirety by reference to the full text of Amendment No. 2 to Employment Offer Letter Agreement.

 

Item 9.01Financial Statements and Exhibits.  

 

(d)Exhibits. 

 

Exhibit Number

 

Description

10.1

 

Amendment No. 2, dated February 21, 2018, to Employment Offer Letter Agreement between the Company and Ronald Fisher.

 

 

 


2


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

February 27, 2018

SIGMA LABS, INC.

 

 

 

 

 

By:/s/ John Rice 

 

Name:John Rice 

 

Title:Interim Chief Executive Officer 

 

 


3